Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription
Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription
批准号:
10798780
负责人:
Zhijie Jason Liu
金额:
$3.27万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-01-31
关键词:
AddressAntiestrogen TherapyBindingBiologicalBiotinBreast Cancer cell lineCell Fate ControlCell LineCell SeparationCellsChIP-seqChromatinDNADNA BindingDataDefectDevelopmentDiseaseDisease ResistanceDistalEP300 geneEnhancersEpigenetic ProcessEquipmentEstradiolEstrogen Receptor alphaEstrogen ReceptorsEstrogensFlow CytometryFoundationsFunctional disorderFundingFutureGene ExpressionGene Expression ProfileGenetic TranscriptionGenomicsGoalsGrantHormonesImageIndividualKnock-outKnowledgeMammary glandMediatingMediatorMethodologyModelingMolecularNamesNuclear ReceptorsOrganPathway interactionsPhenotypePlayProteinsProteomicsRegulationRegulatory ElementReportingResistanceRoleRunningTamoxifenTechnologyTestingUntranslated RNAXenograft procedurecell growthcofactorcombinatorialconditional knockoutglobal run on sequencinghormone resistanceimprovedin vivoknock-downmammary gland developmentmouse modelnoveloverexpressionparent grantprogramsreceptor functionrecruittargeted treatmenttranscription factoruser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT
Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription
Estrogen (E2 or 17β-estradiol) and its nuclear receptor ERα play a critical role in the normal development
and disease conditions of multiple organs, including the mammary glands, by binding mostly to distal
enhancers. Increasing evidence suggests that functional dysregulation of ERα-bound enhancers can
profoundly alter normal transcriptional programs, resulting in developmental defects, diseases, and hormone
resistance. However, the molecular mechanisms underlying enhancer function/dysfunction are largely
unknown. One of the main objectives of the parent grant, R01GM137009, is to understand how the cooperative
interactions between YAP/TEAD and ERα control the context-specific function of ERα-bound enhancers in vivo
through enhancer reprogramming. Specifically relevant to this supplement application, we aim to determine the
functional attributes of YAP/TEAD in enhancer reprogramming during mammary gland development. To
achieve this goal, we plan to dissect mammary glands from mouse models (YAP knockout and overexpression
models) and isolate single cells for cell sorting or cellular phenotype analysis through flow cytometry. We are
requesting equipment funding to purchase a single-cell dissociator combined with a user-friendly flow
cytometer that will allow us to perform phenotype analysis of the mammary glands. This equipment is critical
for my lab to complete this parental R01 project.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fonc.2021.753051
发表时间:
2021
期刊:
Frontiers in oncology
影响因子:
4.7
作者:
[Zboril E, Yoo H, Chen L, Liu Z]
通讯作者:
Liu Z
Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription
-
批准号:10331045
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2020
-
负责人:Zhijie Jason Liu
-
依托单位:
Novel Coregulators of Estrogen Receptor in Enhancer-regulated Transcription
-
批准号:10549772
-
项目类别:
-
资助金额:$6.2万
-
财政年份:2020
-
负责人:Zhijie Jason Liu
-
依托单位:
海外基金